Full-Time

VP Product Development

Infusion Systems, R&D

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Medical technology for diagnostics and care

Healthcare

Compensation Overview

$228.6k - $411.5kAnnually

Expert

San Diego, CA, USA

Role is hybrid and requires a minimum of 4 days in-office presence per week.

Category
Product Management
Product Research
Product

You match the following Becton Dickinson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • B.S., M.S in Computer Science/Software/Mechanical/Electrical Engineering/Biomedical Engineering or related field required; PhD preferred
  • Minimum of fifteen years relevant experience with at least ten years of applicable managerial experience in R&D management at a suitable leadership level
  • Strong people development and delegation skills
  • Demonstrated strategic mindset to complement (and/or constructively challenge) business leaders on connected medication management
  • Experience managing a large R&D organization, preferably responsible for connected, Class II/III electromechanical medical solutions in the acute care space
  • Experience with training, mentoring and teaching in a highly technical environment
  • Demonstrated ability to drive change in large, complex organizations
Responsibilities
  • Drive global, innovation, new product development and life-cycle management of infusion solution portfolio
  • Establish strategy and direction for infusion solution technology development and insource/outsource development activities
  • Provide leadership and overall management of a team of firmware, application software, enterprise software, systems, and hardware engineers
  • Demonstrate managerial ambidexterity by appropriately balancing long-term innovation with short-term product development
  • Recruit/select best in class talent and functional leaders for development of connected electromechanical solutions
  • Routinely evaluate department capacity and capability relative to total demand for firmware, software and hardware engineering capability
  • Proactively identify customer, technologies and/or market trends in connected medication management
  • Accountable for managing priorities of dispensing R&D associate activity and ensure compliance to budget
  • Identify synergistic strategic opportunities with development partners to execute platform initiatives
Desired Qualifications
  • Strong technical skills with agility to think architecturally or employ a '1st principles' approach depending on the situation
  • Direct experience managing large electromechanical systems/hardware project teams serving the acute care space
  • Extensive experience in addressing interoperability requirements with hospital and pharmacy information systems and hospital Internet-of-Things applications

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on solutions for medication management and delivery; BD Life Sciences, which offers products for the safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare environments.

Company Size

10,001+

Company Stage

IPO

Total Funding

$449.4K

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...